Efficacy and tolerance of infliximab in children and adolescents with Crohn's disease
✍ Scribed by Dr. Thierry Lamireau; Jean-Pierre Cézard; Alain Dabadie; Olivier Goulet; Alain Lachaux; Dominique Turck; Chantal Maurage; Alain Morali; Etienne Sokal; Dominique Belli; Joaquim Stoller; Samy Cadranel; Jean-Louis Ginies; Sheila Viola; Frédéric Huet; Jane Languepin; Catherine Lenaerts; Françoise Bury; Jacques Sarles
- Book ID
- 110086291
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 137 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Background: Thiopurines are considered first-line immunomodulators for the prevention of relapse in moderate to severe pediatric crohn's disease (cd). early introduction of thiopurines was shown in a pediatric trial to maintain steroid-free remission in 90% of patients for 18 months. in the pres